August 28, 2012 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Launch of TENELIA® 20mg Tablets - Dipeptidyl peptidase - Document - PDFSEARCH.IO

First Page	Meta Content
	August 28, 2012 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Launch of TENELIA® 20mg Tablets Add to Reading List Document Date: 2012-08-27 03:43:16 Open Document File Size: 30,84 KB Share Result on Facebook City TOKYO / OSAKA / / Company Daiichi Sankyo Co. Ltd. / Mitsubishi Tanabe Pharma Corporation / / Country Japan / / Event Business Partnership / / IndustryTerm food ingestion / treatment of diabetes / / MedicalCondition diabetes mellitus / disease / diabetes / / Person Michihiro Tsuchiya / Joji Nakayama / / / Position President & Representative / Head Office / President & CEO / Director / / Product glucagon / 20mg / / SocialTag Glucagon-like peptide-1 Mitsubishi companies Daiichi Sankyo Dipeptidyl peptidase-4 inhibitor Chūō-ku, Osaka

August 28, 2012 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Launch of TENELIA® 20mg TabletsAdd to Reading List